Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice

BACKGROUND: Stroke is a leading cause of death and disability worldwide, yet there are limited treatments available. Intranasal administration is a novel non-invasive strategy to deliver cell therapy into the brain. Cells delivered via the intranasal route can migrate from the nasal mucosa to the is...

Descripción completa

Detalles Bibliográficos
Autores principales: Chau, Monica J., Deveau, Todd C., Gu, Xiaohuan, Kim, Yo Sup, Xu, Yun, Yu, Shan Ping, Wei, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897929/
https://www.ncbi.nlm.nih.gov/pubmed/29649974
http://dx.doi.org/10.1186/s12868-018-0418-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897929/
https://www.ncbi.nlm.nih.gov/pubmed/29649974
http://dx.doi.org/10.1186/s12868-018-0418-z

Ejemplares similares